Avoid common mistakes on your manuscript.
Publisher Correction: PharmacoEconomics - Open https://doi.org/10.1007/s41669-024-00511-9
During the production process, the figures in this article were inadvertently mixed up. They should be as follows.
Distribution of manufacturers’ and CADTH reanalysis ICUR values for 67 CADTH reports from 2018 to 2022 for non-oncology medications
Distribution of 76 3-year budget impact analysis results of manufacturer’s reports compared to the CADTH reanalysis reports from 2018 to 2022 for non-oncology medications
Price reduction requested by CADTH based on therapeutic categories for non-oncology medications
Willingness to pay threshold mentioned in CADTH price reduction requests from 2018 to 2022 for non-oncology medications
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Mirzayeh Fashami, F., Tarride, JE., Sadeghirad, B. et al. Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses. PharmacoEconomics Open (2024). https://doi.org/10.1007/s41669-024-00522-6
Published:
DOI: https://doi.org/10.1007/s41669-024-00522-6